Invitae Corporation (NVTA)
(Delayed Data from NYSE)
$24.76 USD
+0.60 (2.48%)
Updated May 3, 2019 04:02 PM ET
After-Market: $24.77 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$24.76 USD
+0.60 (2.48%)
Updated May 3, 2019 04:02 PM ET
After-Market: $24.77 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Pick These Top-Ranked Stocks to Deck Up Your Christmas Tree
by Sweta Killa
We have crafted a tree with the most flourishing stocks of 2023 and the ones that are poised to soar in 2024.
Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock
by Zacks Equity Research
Invitae (NVTA) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
What Makes Invitae (NVTA) a New Buy Stock
by Zacks Equity Research
Invitae (NVTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Invitae (NVTA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Invitae (NVTA) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Invitae (NVTA) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Invitae (NVTA) delivered earnings and revenue surprises of 18.92% and 0.54%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Tabula Rasa Healthcare (TRHC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 135.71% and 1.37%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Invitae (NVTA) Upgraded to Buy: Here's Why
by Zacks Equity Research
Invitae (NVTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Invitae (NVTA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Invitae (NVTA) delivered earnings and revenue surprises of 9.76% and 1.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Omnicell (OMCL) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Omnicell (OMCL) delivered earnings and revenue surprises of 457.14% and 4.96%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Invitae (NVTA) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Invitae (NVTA) delivered earnings and revenue surprises of 38.18% and 1.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Invitae (NVTA) delivered earnings and revenue surprises of 28.81% and 0.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of 8.20% and 14.37%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Invitae (NVTA) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Invitae (NVTA) delivered earnings and revenue surprises of 8.11% and 0.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 0% and 11.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 15.96% and 2.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate 1Life Healthcare, Inc. (ONEM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
1Life Healthcare, Inc. (ONEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Invitae (NVTA) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Invitae (NVTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bears are Losing Control Over Invitae (NVTA), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Invitae (NVTA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Signify (SGFY) Stock Jumps 6%: Will It Continue to Soar?
by Zacks Equity Research
Signify (SGFY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks Value Investor Highlights: Chevron, The Andersons, KB Home, Shopify and Invitae
by Zacks Equity Research
Chevron, The Andersons, KB Home, Shopify and Invitae have been highlighted in this Value Investor article.
This Book Changed Warren Buffett's Life
by Tracey Ryniec
First published 73 years ago, the Intelligent Investor is still considered a must-read for value investors.
Invitae (NVTA) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Invitae (NVTA) delivered earnings and revenue surprises of -1.30% and 2.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Invitae (NVTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Invitae (NVTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Market Edge Highlights: Shopify, Block, PayPal, Skillz, and Invitae Corp
by Zacks Equity Research
Shopify, Block, PayPal, Skillz, and Invitae Corp are part of Today's Market Edge Blog.
Growth Stocks: Sell or Buy More?
by Tracey Ryniec
With some growth stocks down over 50% in 2022, what should investors do?